Paper39699210
Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients.
Kumta N and 11 others. Antimicrob Agents Chemother, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients. Papers, record 39699210. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39699210
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Piperacillin, Tazobactam Drug Combination | Major topic |
| Anti-Bacterial Agents | Major topic |
| Cerebral Ventriculitis | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Critical Illness | |
| Male | |
| Aged | |
| Piperacillin | |
| Adult | |
| Tazobactam | |
| Microbial Sensitivity Tests |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Intensive Care Foundation (ICF) | PubMed | |||
| Royal Brisbane and Women's Hospital Foundation (RBWH Foundation) | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17485505 | Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17485505 | PubMed |
| 2 | 25219657 | Meta-analysis identifies tumor necrosis factor-alpha and interleukin-1 beta as diagnostic biomarkers for bacterial and aseptic meningitis. | Curr Neurovasc Res | 2014 | https://conductscience.org/library/papers/25219657 | PubMed |
| 3 | 8383655 | The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. | J Antimicrob Chemother | 1993 | https://conductscience.org/library/papers/8383655 | PubMed |
| 4 | 24752260 | Population pharmacokinetic analysis of piperacillin in burn patients. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24752260 | PubMed |
| 5 | 12205070 | Pharmacodynamics of cefepime in patients with Gram-negative infections. | J Antimicrob Chemother | 2002 | https://conductscience.org/library/papers/12205070 | PubMed |
| 6 | 18313273 | Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. | Int J Antimicrob Agents | 2008 | https://conductscience.org/library/papers/18313273 | PubMed |
| 7 | 35625262 | Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35625262 | PubMed |
| 8 | 28905331 | Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections? | Clin Pharmacokinet | 2018 | https://conductscience.org/library/papers/28905331 | PubMed |
| 9 | 30589457 | Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors. | Pharmacotherapy | 2019 | https://conductscience.org/library/papers/30589457 | PubMed |
| 10 | 29385448 | Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers. | J Antimicrob Chemother | 2018 | https://conductscience.org/library/papers/29385448 | PubMed |
| 11 | 25632974 | Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance? | Crit Care | 2015 | https://conductscience.org/library/papers/25632974 | PubMed |
| 12 | 30707668 | Mean Body Weight, Height, Waist Circumference, and Body Mass Index Among Adults: United States, 1999-2000 Through 2015-2016. | Natl Health Stat Report | 2018 | https://conductscience.org/library/papers/30707668 | PubMed |
| 13 | 25567583 | A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections. | BMC Infect Dis | 2015 | https://conductscience.org/library/papers/25567583 | PubMed |
| 14 | 34600447 | Diagnostic value of cerebrospinal fluid levels of D-lactate, tumour necrosis factor-alpha and interleukin-6, -8, and -17 in suspected nosocomial meningitis. | Singapore Med J | 2024 | https://conductscience.org/library/papers/34600447 | PubMed |
| 15 | 27736759 | Pharmacokinetics of Piperacillin in Critically Ill Australian Indigenous Patients with Severe Sepsis. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27736759 | PubMed |
| 16 | 30289173 | Beta-lactam-induced severe neutropaenia: a descriptive study. | Fundam Clin Pharmacol | 2019 | https://conductscience.org/library/papers/30289173 | PubMed |
| 17 | 24768475 | Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. | Lancet Infect Dis | 2014 | https://conductscience.org/library/papers/24768475 | PubMed |
| 18 | 25643277 | Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development. | Semin Respir Crit Care Med | 2015 | https://conductscience.org/library/papers/25643277 | PubMed |
| 19 | 28052849 | Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28052849 | PubMed |
| 20 | 24429437 | DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24429437 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42318924 | A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/42318924 | PubMed |
| 41310458 | Clinical characteristics and management of Listeria monocytogenes meningitis in children beyond the neonatal stage: a 10 years retrospective study. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/41310458 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39699210
GET https://conductscience.org/api/papers/v1/39699210/references?page=2